• Publications
  • Influence
Apendagitis epiploica recidivada contralateral
TLDR
A review of current evidence of olmesartan medoxomil mimicking symptoms of celiac disease and the FDA approves label changes to include intestinal problems (sprue--like enteropathy) linked to blood pressure medicine olmesartsan medxomil. Expand